Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
299,000
+3,000 (1.01%)
At close: Sep 15, 2025

Hanmi Pharm. Revenue

Hanmi Pharm. had revenue of 361.28B KRW in the quarter ending June 30, 2025, a decrease of -4.46%. This brings the company's revenue in the last twelve months to 1.47T, down -6.56% year-over-year. In the year 2024, Hanmi Pharm. had annual revenue of 1.50T with 0.31% growth.

Revenue (ttm)
1,465.91B
Revenue Growth
-6.56%
P/S Ratio
2.59
Revenue / Employee
625.65M
Employees
2,343
Market Cap
3,791.38B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241,495.50B4.61B0.31%
Dec 31, 20231,490.89B159.34B11.97%
Dec 31, 20221,331.55B128.36B10.67%
Dec 31, 20211,203.19B127.33B11.84%
Dec 31, 20201,075.85B-37.80B-3.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
PharmaResearch449.81B
ABL Bio94.93B
Revenue Rankings